211:@0.890183:0.033217:0.921227:0.033217:0.921227:0.013052:0.890183:0.013052:0.010348:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056390:0.958557:0.056390:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158618:-0.158618:0.000000:0.000000:0.000000:0.000000:0.242660:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
rier to scratching. There is only low-quality evidence that :@0.089630:0.084931:0.485128:0.084931:0.485128:0.069149:0.089630:0.069149:0.004248:0.002721:0.009525:0.004248:0.003689:0.004823:0.009601:0.003689:0.005564:0.009480:0.004248:0.010024:0.004823:0.009480:0.008920:0.002721:0.008920:0.009873:0.003886:0.003689:0.006138:0.008920:0.009525:0.004248:0.009525:0.003689:0.002721:0.005564:0.003689:0.009601:0.008920:0.002721:0.007801:0.003689:0.002721:0.009601:0.012262:0.004717:0.010009:0.008890:0.010024:0.002721:0.002721:0.004823:0.007801:0.003689:0.009525:0.008074:0.002721:0.010054:0.009525:0.008920:0.009480:0.009525:0.003689:0.004823:0.008920:0.010024:0.005125:0.004188
wet-wrap therapy is more effective than standard ther-:@0.089630:0.098867:0.481001:0.098867:0.481001:0.083084:0.089630:0.083084:0.012262:0.009525:0.004823:0.004717:0.012262:0.004248:0.010024:0.010009:0.004445:0.004823:0.008920:0.009525:0.004248:0.010024:0.010009:0.007801:0.004445:0.002721:0.005564:0.004445:0.013879:0.009601:0.004248:0.009525:0.004445:0.009525:0.004445:0.004445:0.009525:0.009480:0.004823:0.002721:0.008074:0.009525:0.004445:0.004823:0.008920:0.010024:0.008920:0.004445:0.005564:0.004823:0.010024:0.008920:0.010054:0.010024:0.004248:0.010054:0.004445:0.004823:0.008920:0.009525:0.004248:0.005020
apy in atopic dermatitis.  Wet-wrap therapy use should :@0.089630:0.112802:0.485139:0.112797:0.485139:0.097014:0.089630:0.097019:0.010024:0.010009:0.007801:0.004717:0.002721:0.008920:0.004717:0.010024:0.004823:0.009601:0.010009:0.002721:0.009480:0.004717:0.010054:0.009525:0.004248:0.013879:0.010024:0.004823:0.002721:0.004823:0.002721:0.005564:0.004188:0.004395:0.004717:0.014212:0.009525:0.004823:0.004717:0.012262:0.004248:0.010024:0.010009:0.004717:0.004823:0.008920:0.009525:0.004248:0.010024:0.010009:0.007801:0.004717:0.008890:0.005564:0.009525:0.004717:0.005564:0.008920:0.009601:0.008890:0.002721:0.010357:0.701531
7:@0.262196:0.107498:0.267054:0.107498:0.267054:0.098344:0.262196:0.098344:0.004858
not exceed 14 days as it increases the risk of localised in-:@0.089625:0.126732:0.480951:0.126732:0.480951:0.110949:0.089625:0.110949:0.008920:0.009601:0.004823:0.003492:0.009525:0.006955:0.009480:0.009525:0.009525:0.010054:0.003492:0.008074:0.008074:0.003492:0.010054:0.010024:0.007801:0.005564:0.003492:0.010024:0.005564:0.003492:0.002721:0.004823:0.003492:0.002721:0.008920:0.009480:0.004248:0.009525:0.010024:0.005564:0.009525:0.005564:0.003492:0.004823:0.008920:0.009525:0.003492:0.004248:0.002721:0.005564:0.007287:0.003492:0.009601:0.004445:0.003492:0.002721:0.009601:0.009480:0.010024:0.002721:0.002721:0.005564:0.009525:0.010054:0.003492:0.002721:0.008920:0.005020
fection, striae and skin atrophy, especially in vulnerable :@0.089625:0.140667:0.485154:0.140667:0.485154:0.124885:0.089625:0.124885:0.004445:0.009525:0.009480:0.004823:0.002721:0.009601:0.008920:0.003886:0.004505:0.005564:0.004823:0.004248:0.002721:0.010024:0.009525:0.004505:0.010024:0.008920:0.010054:0.004505:0.005564:0.007287:0.002721:0.008920:0.004505:0.010024:0.004823:0.004248:0.009601:0.010009:0.008920:0.007801:0.003886:0.004505:0.009525:0.005564:0.010009:0.009525:0.009480:0.002721:0.010024:0.002721:0.002721:0.007801:0.004505:0.002721:0.008920:0.004505:0.008074:0.008890:0.002721:0.008920:0.009525:0.004248:0.010024:0.010009:0.002721:0.009827:0.004188
sites, such as the intertriginous areas.:@0.089625:0.154603:0.344018:0.154603:0.344018:0.138820:0.089625:0.138820:0.005564:0.002721:0.004823:0.009525:0.005564:0.003886:0.003886:0.005564:0.008890:0.009480:0.008920:0.003886:0.010024:0.005564:0.003886:0.004823:0.008920:0.009525:0.003886:0.002721:0.008920:0.004823:0.009525:0.004248:0.004823:0.004248:0.002721:0.009873:0.002721:0.008920:0.009601:0.008890:0.005564:0.003886:0.010024:0.004248:0.009525:0.010024:0.005564:0.004188
Adverse effects of topical corticosteroids:@0.076184:0.182647:0.374634:0.182647:0.374634:0.166148:0.076184:0.166148:0.011188:0.009979:0.008467:0.009676:0.004838:0.006652:0.009676:0.004233:0.009676:0.004233:0.004233:0.009676:0.009676:0.004536:0.006652:0.004233:0.009676:0.004233:0.004233:0.004536:0.009676:0.009979:0.003629:0.009676:0.009979:0.003629:0.004233:0.009676:0.009676:0.004838:0.004536:0.003629:0.009676:0.009676:0.006652:0.004536:0.009676:0.004838:0.009676:0.003629:0.009979:0.006652
The chronic use of potent topical corticosteroids is limited :@0.076184:0.199145:0.485199:0.199145:0.485199:0.183362:0.076184:0.183362:0.006290:0.009071:0.009676:0.003372:0.009631:0.009071:0.004400:0.009752:0.009071:0.002873:0.009631:0.003372:0.009041:0.005715:0.009676:0.003372:0.009752:0.004596:0.003372:0.010160:0.009752:0.004974:0.009676:0.009071:0.004974:0.003372:0.004974:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.003372:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.005715:0.003372:0.002873:0.005715:0.003372:0.002873:0.002873:0.014030:0.002873:0.004974:0.009676:0.010357:0.004188
by the adverse effects, including atrophy, telangiecta-:@0.076184:0.213080:0.480966:0.213080:0.480966:0.197298:0.076184:0.197298:0.010160:0.007953:0.006108:0.004974:0.009071:0.009676:0.006108:0.010175:0.010205:0.008225:0.009676:0.004400:0.005715:0.009676:0.006108:0.009676:0.004596:0.004596:0.009676:0.009631:0.004974:0.005715:0.004037:0.006108:0.002873:0.009071:0.009631:0.002873:0.009041:0.010205:0.002873:0.009071:0.010024:0.006108:0.010175:0.004974:0.004400:0.009752:0.010160:0.009071:0.007953:0.004037:0.006108:0.004974:0.009676:0.002873:0.010175:0.009071:0.010024:0.002873:0.009676:0.009631:0.004974:0.010175:0.005020
sia, striae, topical corticosteroid-induced acne and rosa-:@0.076184:0.227016:0.480920:0.227016:0.480920:0.211233:0.076184:0.211233:0.005715:0.002873:0.010175:0.004037:0.003734:0.005715:0.004974:0.004400:0.002873:0.010175:0.009676:0.004037:0.003734:0.004974:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.003734:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.004868:0.002873:0.009071:0.010205:0.009041:0.009631:0.009676:0.010205:0.003734:0.010175:0.009631:0.009071:0.009676:0.003734:0.010175:0.009071:0.010205:0.003734:0.004400:0.009752:0.005715:0.010175:0.005020
cea, and perioral derma titis. If used peri-orbitally, there is :@0.076184:0.240951:0.485093:0.240951:0.485093:0.225168:0.076184:0.225168:0.009631:0.009676:0.010175:0.004037:0.004052:0.010175:0.009071:0.010205:0.004052:0.010160:0.009676:0.004400:0.002873:0.009752:0.004400:0.010175:0.002873:0.004052:0.010205:0.009676:0.004400:0.014030:0.010175:0.000000:0.004974:0.002873:0.004974:0.002873:0.005715:0.004037:0.004052:0.003266:0.004596:0.004052:0.009041:0.005715:0.009676:0.010205:0.004052:0.010160:0.009676:0.004400:0.002873:0.004868:0.009752:0.004400:0.010160:0.002873:0.004974:0.010175:0.002873:0.002873:0.007953:0.004037:0.004052:0.004974:0.009071:0.009676:0.004400:0.009676:0.004052:0.002873:0.005866:0.004188
a risk of glaucoma, cataracts and herpes keratitis. The risk :@0.076184:0.254886:0.485199:0.254886:0.485199:0.239104:0.076184:0.239104:0.010175:0.003266:0.004400:0.002873:0.005715:0.007439:0.003266:0.009752:0.004596:0.003266:0.010024:0.002873:0.010175:0.009041:0.009631:0.009752:0.014030:0.010175:0.004037:0.003266:0.009631:0.010175:0.004974:0.010175:0.004400:0.010175:0.009631:0.004974:0.005715:0.003266:0.010175:0.009071:0.010205:0.003266:0.009071:0.009676:0.004400:0.010160:0.009676:0.005715:0.003266:0.007439:0.009676:0.004400:0.010175:0.004974:0.002873:0.004974:0.002873:0.005715:0.004037:0.003266:0.006290:0.009071:0.009676:0.003266:0.004400:0.002873:0.005715:0.007590:0.004188
of hypothalamus-pituitary axis suppression is low, but in-:@0.076184:0.268822:0.480966:0.268822:0.480966:0.253039:0.076184:0.253039:0.009752:0.004596:0.005458:0.009071:0.007953:0.010160:0.009752:0.004974:0.009071:0.010175:0.002873:0.010175:0.014030:0.009041:0.005715:0.004868:0.010160:0.002873:0.004974:0.009041:0.002873:0.004974:0.010175:0.004400:0.007953:0.005458:0.010175:0.007106:0.002873:0.005715:0.005458:0.005715:0.009041:0.010160:0.010160:0.004400:0.009676:0.005715:0.005715:0.002873:0.009752:0.009071:0.005458:0.002873:0.005715:0.005458:0.002873:0.009752:0.012413:0.004037:0.005458:0.010160:0.009041:0.004974:0.005458:0.002873:0.009071:0.005020
creases with prolonged, continuous use of high-potency :@0.076184:0.282757:0.485199:0.282757:0.485199:0.266975:0.076184:0.266975:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.005715:0.004264:0.012413:0.002873:0.004974:0.009071:0.004264:0.010160:0.004400:0.009752:0.002873:0.009752:0.009071:0.010024:0.009676:0.010205:0.004037:0.004264:0.009631:0.009752:0.009071:0.004974:0.002873:0.009071:0.009041:0.009752:0.009041:0.005715:0.004264:0.009041:0.005715:0.009676:0.004264:0.009752:0.004596:0.004264:0.009071:0.002873:0.010024:0.009071:0.004868:0.010160:0.009752:0.004974:0.009676:0.009071:0.009631:0.008104:0.004188
classes in individuals receiving concurrent corticosteroids :@0.076184:0.296692:0.485108:0.296692:0.485108:0.280910:0.076184:0.280910:0.009631:0.002873:0.010175:0.005715:0.005715:0.009676:0.005715:0.003719:0.002873:0.009071:0.003719:0.002873:0.009071:0.010205:0.002873:0.008225:0.002873:0.010205:0.009041:0.010175:0.002873:0.005715:0.003719:0.004400:0.009676:0.009631:0.009676:0.002873:0.008225:0.002873:0.009071:0.010024:0.003719:0.009631:0.009752:0.009071:0.009631:0.009041:0.004400:0.004400:0.009676:0.009071:0.004974:0.003719:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.005866:0.004188
in other forms (inhaled, intranasal or oral) and small chil-:@0.076184:0.310628:0.480951:0.310628:0.480951:0.294845:0.076184:0.294845:0.002873:0.009071:0.004687:0.009752:0.004974:0.009071:0.009676:0.004400:0.004687:0.004596:0.009752:0.004400:0.014030:0.005715:0.004687:0.005428:0.002873:0.009071:0.009071:0.010175:0.002873:0.009676:0.010205:0.004037:0.004687:0.002873:0.009071:0.004974:0.004400:0.010175:0.009071:0.010175:0.005715:0.010175:0.002873:0.004687:0.009752:0.004400:0.004687:0.009752:0.004400:0.010175:0.002873:0.005428:0.004687:0.010175:0.009071:0.010205:0.004687:0.005715:0.014030:0.010175:0.002873:0.002873:0.004687:0.009631:0.009071:0.002873:0.002873:0.005020
dren.:@0.076184:0.324563:0.113724:0.324563:0.113724:0.308781:0.076184:0.308781:0.010205:0.004400:0.009676:0.009071:0.004188
topical calcineurin inhibitors:@0.076184:0.353889:0.284222:0.353889:0.284222:0.337390:0.076184:0.337390:0.006350:0.009676:0.009979:0.003629:0.009676:0.009979:0.003629:0.004233:0.009676:0.009979:0.003629:0.009676:0.003629:0.009071:0.009676:0.009071:0.004838:0.003629:0.009071:0.004233:0.003629:0.009071:0.009071:0.003629:0.009979:0.003629:0.004536:0.009676:0.004838:0.006652
Topical calcineurin inhibitors (TCI) are immunomodula-:@0.076184:0.370387:0.480936:0.370387:0.480936:0.354604:0.076184:0.354604:0.006441:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.005594:0.009782:0.010326:0.003024:0.009782:0.003024:0.009223:0.009827:0.009192:0.004551:0.003024:0.009223:0.005594:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.005594:0.005579:0.006441:0.012292:0.003417:0.005579:0.005594:0.010326:0.004551:0.009827:0.005594:0.003024:0.014182:0.014182:0.009192:0.009223:0.009903:0.014182:0.009903:0.010357:0.009192:0.003024:0.010326:0.005020
tors that work by inhibiting calcineurin in the skin, thus :@0.076184:0.384322:0.485139:0.384322:0.485139:0.368540:0.076184:0.368540:0.005125:0.009903:0.004551:0.005866:0.006048:0.005125:0.009223:0.010326:0.005125:0.006048:0.012564:0.009903:0.004551:0.007590:0.006048:0.010311:0.008104:0.006048:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003024:0.009223:0.010175:0.006048:0.009782:0.010326:0.003024:0.009782:0.003024:0.009223:0.009827:0.009192:0.004551:0.003024:0.009223:0.006048:0.003024:0.009223:0.006048:0.005125:0.009223:0.009827:0.006048:0.005866:0.007590:0.003024:0.009223:0.004188:0.006048:0.005125:0.009223:0.009192:0.005866:0.004188
inhibiting T-cell proliferation and the production of pro-:@0.076184:0.398258:0.480951:0.398258:0.480951:0.382475:0.076184:0.382475:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.003024:0.009223:0.010175:0.004989:0.006441:0.005020:0.009782:0.009827:0.003024:0.003024:0.004989:0.010311:0.004551:0.009903:0.003024:0.003024:0.004747:0.009827:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004974:0.010326:0.009223:0.010357:0.004974:0.005125:0.009223:0.009827:0.004974:0.010311:0.004551:0.009903:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004974:0.009903:0.004747:0.004974:0.010311:0.004551:0.009903:0.005020
inflammatory cytokines involved in the pathogenesis of :@0.076184:0.412193:0.485124:0.412193:0.485124:0.396411:0.076184:0.396411:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004687:0.009782:0.008104:0.005125:0.009903:0.007590:0.003024:0.009223:0.009827:0.005866:0.004687:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.010357:0.004702:0.003024:0.009223:0.004702:0.005125:0.009223:0.009827:0.004687:0.010311:0.010326:0.005125:0.009223:0.009903:0.010175:0.009827:0.009223:0.009827:0.005866:0.003024:0.005866:0.004687:0.009903:0.004747:0.004188
atopic dermatitis.:@0.076184:0.426129:0.204439:0.426129:0.204439:0.410346:0.076184:0.410346:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.004188:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004188
Two  topical  calcineurin  inhibitors  are  available,  i.e., :@0.090471:0.440064:0.485093:0.440064:0.485093:0.424281:0.090471:0.424281:0.006290:0.012413:0.009752:0.004188:0.004173:0.004974:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.004188:0.004173:0.009631:0.010175:0.002873:0.009631:0.002873:0.009071:0.009676:0.009041:0.004400:0.002873:0.009071:0.004188:0.004173:0.002873:0.009071:0.009071:0.002873:0.010160:0.002873:0.004974:0.009752:0.004400:0.005715:0.004188:0.004173:0.010175:0.004400:0.009676:0.004188:0.004173:0.010175:0.008225:0.010175:0.002873:0.002873:0.010175:0.010160:0.002873:0.009676:0.004037:0.004188:0.004173:0.002873:0.004037:0.009676:0.004037:0.004188:0.004188
pimecrolimus cream (1%) and tacrolimus ointment :@0.076184:0.453999:0.485124:0.453999:0.485124:0.438217:0.076184:0.438217:0.010160:0.002873:0.014030:0.009676:0.009631:0.004400:0.009752:0.002873:0.002873:0.014030:0.009041:0.005715:0.012730:0.009631:0.004400:0.009676:0.010175:0.014030:0.012730:0.005428:0.008225:0.011566:0.005428:0.012730:0.010175:0.009071:0.010205:0.012730:0.004974:0.010175:0.009631:0.004400:0.009752:0.002873:0.002873:0.014030:0.009041:0.005715:0.012730:0.009752:0.002873:0.009071:0.004974:0.014030:0.009676:0.009071:0.005125:0.004188
(0.03% and 0.1%). Topical calcineurin inhibitors have :@0.076184:0.467935:0.485139:0.467935:0.485139:0.452152:0.076184:0.452152:0.005428:0.008225:0.004037:0.008225:0.008225:0.011566:0.009661:0.010175:0.009071:0.010205:0.009661:0.008225:0.004037:0.008225:0.011566:0.005428:0.004037:0.009661:0.006290:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.009661:0.009631:0.010175:0.002873:0.009631:0.002873:0.009071:0.009676:0.009041:0.004400:0.002873:0.009071:0.009661:0.002873:0.009071:0.009071:0.002873:0.010160:0.002873:0.004974:0.009752:0.004400:0.005715:0.009661:0.009071:0.010175:0.008225:0.009827:0.004188
been shown to decrease the physician’s global evalua-:@0.076184:0.481870:0.480951:0.481870:0.480951:0.466087:0.076184:0.466087:0.010160:0.009676:0.009676:0.009071:0.004732:0.005715:0.009071:0.009752:0.012413:0.009071:0.004732:0.004974:0.009752:0.004732:0.010205:0.009676:0.009631:0.004400:0.009676:0.010175:0.005715:0.009676:0.004732:0.004974:0.009071:0.009676:0.004732:0.010160:0.009071:0.007953:0.005715:0.002873:0.009631:0.002873:0.010175:0.009071:0.005156:0.005715:0.004732:0.010024:0.002873:0.009752:0.010160:0.010175:0.002873:0.004732:0.009676:0.008225:0.010175:0.002873:0.009041:0.010175:0.005020
tion scores, as well as the percentage of body-surface :@0.076184:0.495805:0.485093:0.495805:0.485093:0.480023:0.076184:0.480023:0.004974:0.002873:0.009752:0.009071:0.005957:0.005715:0.009631:0.009752:0.004400:0.009676:0.005715:0.004037:0.005957:0.010175:0.005715:0.005957:0.012413:0.009676:0.002873:0.002873:0.005957:0.010175:0.005715:0.005957:0.004974:0.009071:0.009676:0.005957:0.010160:0.009676:0.004400:0.009631:0.009676:0.009071:0.004974:0.010175:0.010024:0.009676:0.005957:0.009752:0.004596:0.005957:0.010160:0.009752:0.010205:0.007953:0.004868:0.005715:0.009041:0.004400:0.004596:0.010175:0.009631:0.009827:0.004188
area involved and patient evaluation of symptoms and :@0.076184:0.509741:0.485093:0.509741:0.485093:0.493958:0.076184:0.493958:0.010175:0.004400:0.009676:0.010175:0.004989:0.002873:0.009071:0.008225:0.009752:0.002873:0.008225:0.009676:0.010205:0.004989:0.010175:0.009071:0.010205:0.004989:0.010160:0.010175:0.004974:0.002873:0.009676:0.009071:0.004974:0.004989:0.009676:0.008225:0.010175:0.002873:0.009041:0.010175:0.004974:0.002873:0.009752:0.009071:0.004989:0.009752:0.004596:0.004989:0.005715:0.007953:0.014030:0.010160:0.004974:0.009752:0.014030:0.005715:0.004989:0.010175:0.009071:0.010357:0.004188
signs.  Tacrolimus is approved for moderate- to severe at-:@0.076184:0.523676:0.480984:0.523614:0.480984:0.507831:0.076184:0.507893:0.005715:0.002873:0.010024:0.009071:0.005715:0.004188:0.004629:0.003462:0.006290:0.010175:0.009631:0.004400:0.009752:0.002873:0.002873:0.014030:0.009041:0.005715:0.003462:0.002873:0.005715:0.003462:0.010175:0.010160:0.010160:0.004400:0.009752:0.008225:0.009676:0.010205:0.003462:0.004596:0.009752:0.004400:0.003462:0.014030:0.009752:0.010205:0.009676:0.004400:0.010175:0.004974:0.009676:0.004868:0.003462:0.004974:0.009752:0.003462:0.005715:0.009676:0.008225:0.009676:0.004400:0.009676:0.003462:0.010175:0.004974:0.168542
8:@0.113627:0.518315:0.118485:0.518315:0.118485:0.509161:0.113627:0.509161:0.004858
opic dermatitis, while pimecrolimus is indicated for mild- :@0.076187:0.537549:0.485096:0.537549:0.485096:0.521767:0.076187:0.521767:0.009752:0.010160:0.002873:0.009631:0.004914:0.010205:0.009676:0.004400:0.014030:0.010175:0.004974:0.002873:0.004974:0.002873:0.005715:0.004037:0.004914:0.012413:0.009071:0.002873:0.002873:0.009676:0.004914:0.010160:0.002873:0.014030:0.009676:0.009631:0.004400:0.009752:0.002873:0.002873:0.014030:0.009041:0.005715:0.004914:0.002873:0.005715:0.004914:0.002873:0.009071:0.010205:0.002873:0.009631:0.010175:0.004974:0.009676:0.010205:0.004914:0.004596:0.009752:0.004400:0.004914:0.014030:0.002873:0.002873:0.010205:0.005020:0.004188
to moderate disease. While tacrolimus 0.03% is superior :@0.076187:0.551484:0.485111:0.551484:0.485111:0.535702:0.076187:0.535702:0.004974:0.009752:0.005957:0.014030:0.009752:0.010205:0.009676:0.004400:0.010175:0.004974:0.009676:0.005957:0.010205:0.002873:0.005715:0.009676:0.010175:0.005715:0.009676:0.004037:0.005957:0.014363:0.009071:0.002873:0.002873:0.009676:0.005957:0.004974:0.010175:0.009631:0.004400:0.009752:0.002873:0.002873:0.014030:0.009041:0.005715:0.005957:0.008225:0.004037:0.008225:0.008225:0.011566:0.005957:0.002873:0.005715:0.005957:0.005715:0.009041:0.010160:0.009676:0.004400:0.002873:0.009752:0.004551:0.004188
to low-potency corticosteroids, tacrolimus 0.1% is superior :@0.076187:0.565420:0.485172:0.565420:0.485172:0.549637:0.076187:0.549637:0.004974:0.009752:0.003387:0.002873:0.009752:0.012413:0.004868:0.010160:0.009752:0.004974:0.009676:0.009071:0.009631:0.007953:0.003387:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.005715:0.004037:0.003387:0.004974:0.010175:0.009631:0.004400:0.009752:0.002873:0.002873:0.014030:0.009041:0.005715:0.003387:0.008225:0.004037:0.008225:0.011566:0.003387:0.002873:0.005715:0.003387:0.005715:0.009041:0.010160:0.009676:0.004400:0.002873:0.009752:0.004551:0.004188
to low-potency topical corticosteroids and equivalent :@0.076187:0.579355:0.485127:0.579355:0.485127:0.563573:0.076187:0.563573:0.004974:0.009752:0.007560:0.002873:0.009752:0.012413:0.004868:0.010160:0.009752:0.004974:0.009676:0.009071:0.009631:0.007953:0.007560:0.004974:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.007560:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.005715:0.007560:0.010175:0.009071:0.010205:0.007560:0.009676:0.010160:0.009041:0.002873:0.008225:0.010175:0.002873:0.009676:0.009071:0.005125:0.004188
to moderate- to potent topical corticosteroids.  Hence, :@0.076187:0.593291:0.485149:0.593277:0.485149:0.577494:0.076187:0.577508:0.004974:0.009752:0.005503:0.014030:0.009752:0.010205:0.009676:0.004400:0.010175:0.004974:0.009676:0.004868:0.005503:0.004974:0.009752:0.005503:0.010160:0.009752:0.004974:0.009676:0.009071:0.004974:0.005503:0.004974:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.005503:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.005715:0.004188:0.004573:0.005503:0.010175:0.009676:0.009071:0.009631:0.009676:0.004188:0.072320
8:@0.418268:0.587978:0.423126:0.587978:0.423126:0.578824:0.418268:0.578824:0.004858
both are a suitable alternative to topical corticosteroids :@0.076194:0.607212:0.485164:0.607212:0.485164:0.591430:0.076194:0.591430:0.010160:0.009752:0.004974:0.009071:0.004883:0.010175:0.004400:0.009676:0.004883:0.010175:0.004883:0.005715:0.009041:0.002873:0.004974:0.010175:0.010160:0.002873:0.009676:0.004883:0.010175:0.002873:0.004974:0.009676:0.004400:0.009071:0.010175:0.004974:0.002873:0.008225:0.009676:0.004883:0.004974:0.009752:0.004883:0.004974:0.009752:0.010160:0.002873:0.009631:0.010175:0.002873:0.004883:0.009631:0.009752:0.004400:0.004974:0.002873:0.009631:0.009752:0.005715:0.004974:0.009676:0.004400:0.009752:0.002873:0.010205:0.005866:0.004188
for recalcitrant periorbital or facial eczema.:@0.076194:0.621148:0.388417:0.621148:0.388417:0.605365:0.076194:0.605365:0.004596:0.009752:0.004400:0.004037:0.004400:0.009676:0.009631:0.010175:0.002873:0.009631:0.002873:0.004974:0.004400:0.010175:0.009071:0.004974:0.004037:0.010160:0.009676:0.004400:0.002873:0.009752:0.004400:0.010160:0.002873:0.004974:0.010175:0.002873:0.004037:0.009752:0.004400:0.004037:0.004596:0.010175:0.009631:0.002873:0.010175:0.002873:0.004037:0.009676:0.009631:0.006274:0.009676:0.014030:0.010175:0.004188
The  main role  of  topical calcineurin inhibitors is that :@0.090482:0.635083:0.485149:0.635083:0.485149:0.619300:0.090482:0.619300:0.006441:0.009223:0.009827:0.004188:0.002283:0.014182:0.010326:0.003024:0.009223:0.006486:0.004551:0.009903:0.003024:0.009827:0.004188:0.002283:0.009903:0.004747:0.004188:0.002283:0.005125:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.006486:0.009782:0.010326:0.003024:0.009782:0.003024:0.009223:0.009827:0.009192:0.004551:0.003024:0.009223:0.006486:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005866:0.006486:0.003024:0.005866:0.006486:0.005125:0.009223:0.010326:0.005125:0.004188
of  steroid-sparing  agents,  particularly in sensitive skin :@0.076194:0.649018:0.485119:0.649018:0.485119:0.633236:0.076194:0.633236:0.009903:0.004747:0.004188:0.003931:0.005866:0.005125:0.009827:0.004551:0.009888:0.003024:0.010357:0.005020:0.005866:0.010311:0.010326:0.004551:0.003039:0.009223:0.010175:0.004188:0.003931:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.004188:0.004188:0.003931:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.008134:0.003024:0.009223:0.008134:0.005866:0.009827:0.009223:0.005866:0.003024:0.005125:0.003024:0.008376:0.009827:0.008134:0.005866:0.007590:0.003024:0.009223:0.004188
areas, such as  the face, neck and intertriginous  sites. :@0.076194:0.662954:0.485134:0.662954:0.485134:0.647171:0.076194:0.647171:0.010326:0.004551:0.009827:0.010326:0.005866:0.004188:0.006788:0.005866:0.009192:0.009782:0.009223:0.006788:0.010326:0.005866:0.004188:0.002616:0.005125:0.009223:0.009827:0.006788:0.004747:0.010326:0.009782:0.009827:0.004188:0.006788:0.009223:0.009827:0.009782:0.007590:0.006788:0.010326:0.009223:0.010357:0.006788:0.003024:0.009223:0.005125:0.009827:0.004551:0.005125:0.004551:0.003024:0.010175:0.003024:0.009223:0.009903:0.009192:0.005866:0.004188:0.002585:0.005866:0.003024:0.005125:0.009827:0.005866:0.004188:0.004188
They have also been demonstrated to be more effec-:@0.076194:0.676889:0.480961:0.676889:0.480961:0.661106:0.076194:0.661106:0.006441:0.009223:0.009827:0.008104:0.005352:0.009223:0.010326:0.008376:0.009827:0.005367:0.010326:0.003024:0.005866:0.009903:0.005367:0.010311:0.009827:0.009827:0.009223:0.005352:0.010357:0.009827:0.014182:0.009903:0.009223:0.005866:0.005125:0.004551:0.010326:0.005125:0.009827:0.010357:0.005352:0.005125:0.009903:0.005352:0.010311:0.009827:0.005367:0.014182:0.009903:0.004551:0.009827:0.005352:0.009827:0.004747:0.004747:0.009827:0.009782:0.005020
tive in reversing skin atrophy than the vehicle.:@0.076194:0.690824:0.408117:0.690824:0.408117:0.675042:0.076194:0.675042:0.005125:0.003024:0.008376:0.009827:0.004188:0.003024:0.009223:0.004188:0.004551:0.009827:0.008376:0.009827:0.004551:0.005866:0.003024:0.009223:0.010175:0.004188:0.005866:0.007590:0.003024:0.009223:0.004188:0.010326:0.005125:0.004551:0.009903:0.010311:0.009223:0.008104:0.004188:0.005125:0.009223:0.010326:0.009223:0.004188:0.005125:0.009223:0.009827:0.004188:0.008376:0.009827:0.009223:0.003024:0.009782:0.003024:0.009827:0.004188
Dosing:@0.076190:0.721808:0.131291:0.721808:0.131291:0.703477:0.076190:0.703477:0.011759:0.010751:0.007392:0.004032:0.010079:0.011087
• Tacrolimus 0,03% and pimecrolimus 1% are indicated :@0.076190:0.737913:0.485145:0.737913:0.485145:0.722130:0.076190:0.722130:0.009162:0.004279:0.006441:0.010326:0.009782:0.004551:0.009903:0.003024:0.003024:0.014182:0.009192:0.005866:0.005231:0.008376:0.004188:0.008376:0.008376:0.011717:0.005231:0.010326:0.009223:0.010357:0.005231:0.010311:0.003024:0.014182:0.009827:0.009782:0.004551:0.009903:0.003024:0.003024:0.014182:0.009192:0.005866:0.005231:0.008376:0.011717:0.005231:0.010326:0.004551:0.009827:0.005231:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.004188
for use in patients older than two years, while tacro-:@0.089631:0.751848:0.480957:0.751848:0.480957:0.736066:0.089631:0.736066:0.004747:0.009903:0.004551:0.005745:0.009192:0.005866:0.009827:0.005760:0.003024:0.009223:0.005760:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005760:0.009903:0.003024:0.010357:0.009827:0.004551:0.005745:0.005125:0.009223:0.010326:0.009223:0.005760:0.005125:0.012564:0.009903:0.005745:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.005760:0.012564:0.009223:0.003024:0.003024:0.009827:0.005760:0.005125:0.010326:0.009782:0.004551:0.009888:0.005020
limus 0.1% strength  is approved in those  older  than :@0.089631:0.765784:0.485130:0.765784:0.485130:0.750001:0.089631:0.750001:0.003024:0.003024:0.014182:0.009192:0.005866:0.007212:0.008376:0.004188:0.008376:0.011717:0.007212:0.005866:0.005125:0.004551:0.009827:0.009223:0.010175:0.005125:0.009223:0.004188:0.003009:0.003024:0.005866:0.007212:0.010326:0.010311:0.010311:0.004551:0.009903:0.008376:0.009827:0.010357:0.007212:0.003024:0.009223:0.007212:0.005125:0.009223:0.009903:0.005866:0.009827:0.004188:0.003009:0.009903:0.003024:0.010357:0.009827:0.004551:0.004188:0.003009:0.005125:0.009223:0.010326:0.009223:0.004188
15  years. However, both these agents have been :@0.089631:0.779719:0.485145:0.779719:0.485145:0.763936:0.089631:0.763936:0.008376:0.008376:0.004188:0.004430:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.008603:0.010326:0.009903:0.012564:0.009827:0.008376:0.009827:0.004551:0.004188:0.008603:0.010311:0.009903:0.005125:0.009223:0.008603:0.005125:0.009223:0.009827:0.005866:0.009827:0.008603:0.010326:0.010175:0.009827:0.009223:0.005125:0.005866:0.008603:0.009223:0.010326:0.008376:0.009827:0.008603:0.010311:0.009827:0.009827:0.009223:0.004188
safely and effectively used in children younger than :@0.089631:0.793527:0.485130:0.793527:0.485130:0.777745:0.089631:0.777745:0.005866:0.010326:0.004747:0.009827:0.003024:0.008104:0.005972:0.010326:0.009223:0.010357:0.005957:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.003024:0.008104:0.005972:0.009192:0.005866:0.009827:0.010357:0.005957:0.003024:0.009223:0.005957:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.005957:0.008104:0.009903:0.009192:0.009223:0.010175:0.009827:0.004551:0.005957:0.005125:0.009223:0.010326:0.009223:0.004188
two years of age, in clinical trials,  and off-label use of :@0.089631:0.807336:0.485151:0.807319:0.485151:0.791537:0.089631:0.791553:0.005125:0.012564:0.009903:0.004097:0.008104:0.009827:0.010326:0.004551:0.005866:0.004112:0.009903:0.004747:0.004112:0.010326:0.010175:0.009827:0.004188:0.004097:0.003024:0.009223:0.004112:0.009782:0.003024:0.003024:0.009223:0.003024:0.009782:0.010326:0.003024:0.004112:0.005125:0.004551:0.003024:0.010326:0.003024:0.005866:0.004188:0.004874:0.004112:0.010326:0.009223:0.010357:0.004112:0.009903:0.004747:0.004747:0.005020:0.003024:0.010326:0.010311:0.009827:0.003024:0.004112:0.009192:0.005866:0.009827:0.004112:0.009903:0.004747:-0.207975
9:@0.329282:0.802021:0.334140:0.802021:0.334140:0.792867:0.329282:0.792867:0.004858
tacrolimus 0.1% in children suggests that 0.1% is more :@0.089637:0.821128:0.485136:0.821128:0.485136:0.805345:0.089637:0.805345:0.005125:0.010326:0.009782:0.004551:0.009903:0.003024:0.003024:0.014182:0.009192:0.005866:0.005065:0.008376:0.004188:0.008376:0.011717:0.005065:0.003024:0.009223:0.005065:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.005065:0.005866:0.009192:0.010175:0.010175:0.009827:0.005866:0.005125:0.005866:0.005065:0.005125:0.009223:0.010326:0.005125:0.005065:0.008376:0.004188:0.008376:0.011717:0.005065:0.003024:0.005866:0.005065:0.014182:0.009903:0.004551:0.009827:0.004188
effective than 0.03%.:@0.089637:0.834936:0.242415:0.834936:0.242415:0.819153:0.089637:0.819153:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.004188:0.005125:0.009223:0.010326:0.009223:0.004188:0.008376:0.004188:0.008376:0.008376:0.011717:0.004188
4 :@0.242400:0.829629:0.249687:0.829629:0.249687:0.820475:0.242400:0.820475:0.004858:0.002429
• Twice-daily application is more effective than once-:@0.076190:0.848732:0.480942:0.848732:0.480942:0.832950:0.076190:0.832950:0.009162:0.004279:0.006441:0.012564:0.003024:0.009782:0.009827:0.005020:0.010357:0.010326:0.003024:0.003024:0.008104:0.005866:0.010326:0.010311:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.003024:0.005866:0.005866:0.014182:0.009903:0.004551:0.009827:0.005851:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.005851:0.005125:0.009223:0.010326:0.009223:0.005851:0.009903:0.009223:0.009782:0.009827:0.005020
daily application.:@0.089631:0.862541:0.217221:0.862541:0.217221:0.846758:0.089631:0.846758:0.010357:0.010326:0.003024:0.003024:0.008104:0.004188:0.010326:0.010311:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188
• Topical  corticosteroids  are  more  useful  as  mainte:@0.076190:0.876349:0.475938:0.876349:0.475938:0.860566:0.076190:0.860566:0.009162:0.004279:0.006441:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.004188:0.004808:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188:0.004808:0.010326:0.004551:0.009827:0.004188:0.004808:0.014182:0.009903:0.004551:0.009827:0.004188:0.004808:0.009192:0.005866:0.009827:0.004747:0.009192:0.003024:0.004188:0.004808:0.010326:0.005866:0.004188:0.004823:0.014182:0.010326:0.003024:0.009223:0.005125:0.009827
-:@0.475938:0.876349:0.480957:0.876349:0.480957:0.860566:0.475938:0.860566:0.005020
nance  after  gaining control  with topical cortico-:@0.089631:0.890157:0.480957:0.890157:0.480957:0.874375:0.089631:0.874375:0.009223:0.010326:0.009223:0.009782:0.009827:0.004188:0.006335:0.010326:0.004747:0.005125:0.009827:0.004551:0.004188:0.006335:0.010175:0.010326:0.003024:0.009223:0.003024:0.009223:0.010175:0.010538:0.009782:0.009903:0.009223:0.005125:0.004551:0.009903:0.003024:0.004188:0.006335:0.012564:0.003024:0.005125:0.009223:0.010538:0.005125:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.010538:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009888:0.005020
steroids during acute flares.:@0.089631:0.903966:0.289580:0.903966:0.289580:0.888183:0.089631:0.888183:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188:0.010357:0.009192:0.004551:0.003024:0.009223:0.010175:0.004188:0.010326:0.009782:0.009192:0.005125:0.009827:0.004188:0.003666:0.003666:0.010326:0.004551:0.009827:0.005866:0.004188
• Proactive therapy of twice-weekly application to pre:@0.076190:0.917774:0.475953:0.917774:0.475953:0.901991:0.076190:0.901991:0.009162:0.004279:0.008950:0.004551:0.009903:0.010326:0.009782:0.005125:0.003024:0.008376:0.009827:0.003991:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.003991:0.009903:0.004747:0.003991:0.005125:0.012564:0.003024:0.009782:0.009827:0.005020:0.012564:0.009827:0.009827:0.007590:0.003024:0.008104:0.003991:0.010326:0.010311:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.004007:0.005125:0.009903:0.003991:0.010311:0.004551:0.009827
-:@0.475953:0.917774:0.480972:0.917774:0.480972:0.901991:0.475953:0.901991:0.005020
viously involved sites has been  shown  to  reduce  re-:@0.089631:0.931582:0.480957:0.931582:0.480957:0.915800:0.089631:0.915800:0.008376:0.003024:0.009903:0.009192:0.005866:0.003024:0.008104:0.006592:0.003024:0.009223:0.008376:0.009903:0.003024:0.008376:0.009827:0.010357:0.006592:0.005866:0.003024:0.005125:0.009827:0.005866:0.006592:0.009223:0.010326:0.005866:0.006592:0.010311:0.009827:0.009827:0.009223:0.004188:0.002389:0.005866:0.009223:0.009903:0.012564:0.009223:0.004188:0.002389:0.005125:0.009903:0.004188:0.002389:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.004188:0.002389:0.004551:0.009827:0.005020
lapse rates and prolong time to flares.:@0.089631:0.945391:0.366083:0.945391:0.366083:0.929608:0.089631:0.929608:0.003024:0.010326:0.010311:0.005866:0.009827:0.004188:0.004551:0.010326:0.005125:0.009827:0.005866:0.004188:0.010326:0.009223:0.010357:0.004188:0.010311:0.004551:0.009903:0.003024:0.009903:0.009223:0.010175:0.004188:0.005125:0.003024:0.014182:0.009827:0.004188:0.005125:0.009903:0.004188:0.003666:0.003666:0.010326:0.004551:0.009827:0.005866:0.004188
6:@0.366054:0.940064:0.370912:0.940064:0.370912:0.930910:0.366054:0.930910:0.004858
Adverse effects:@0.519047:0.086287:0.645039:0.086287:0.645039:0.067956:0.519047:0.067956:0.012431:0.011087:0.009407:0.010751:0.005376:0.007392:0.010751:0.004704:0.010751:0.004704:0.004704:0.010751:0.010751:0.005040:0.007392
The most common adverse effect of topical calcineu-:@0.519047:0.102656:0.923860:0.102656:0.923860:0.086873:0.519047:0.086873:0.006138:0.008920:0.009525:0.007363:0.013879:0.009601:0.005564:0.004823:0.007363:0.009480:0.009601:0.013879:0.013879:0.009601:0.008920:0.007363:0.010024:0.010054:0.008074:0.009525:0.004248:0.005564:0.009525:0.007363:0.009525:0.004445:0.004445:0.009525:0.009480:0.004823:0.007363:0.009601:0.004445:0.007363:0.004823:0.009601:0.010009:0.002721:0.009480:0.010024:0.002721:0.007363:0.009480:0.010024:0.002721:0.009480:0.002721:0.008920:0.009525:0.008890:0.005020
rin inhibitors is localised stinging and burning.  However, :@0.519047:0.116857:0.928005:0.116853:0.928005:0.101070:0.519047:0.101074:0.004248:0.002721:0.008920:0.006562:0.002721:0.008920:0.008920:0.002721:0.010009:0.002721:0.004823:0.009601:0.004248:0.005564:0.006562:0.002721:0.005564:0.006562:0.002721:0.009601:0.009480:0.010024:0.002721:0.002721:0.005564:0.009525:0.010054:0.006562:0.005564:0.004823:0.002721:0.008920:0.009873:0.002721:0.008920:0.009873:0.006562:0.010024:0.008920:0.010054:0.006562:0.010009:0.008890:0.004248:0.008920:0.002721:0.008920:0.009873:0.004188:0.004372:0.006562:0.010024:0.009601:0.012262:0.009525:0.008074:0.009525:0.004248:0.004188:0.253352
8:@0.845125:0.111554:0.849983:0.111554:0.849983:0.102400:0.845125:0.102400:0.004858
symptoms are usually mild and transient, and decrease :@0.519050:0.131054:0.927975:0.131054:0.927975:0.115271:0.519050:0.115271:0.005564:0.007801:0.013879:0.010009:0.004823:0.009601:0.013879:0.005564:0.006305:0.010024:0.004248:0.009525:0.006305:0.008890:0.005564:0.008890:0.010024:0.002721:0.002721:0.007801:0.006305:0.013879:0.002721:0.002721:0.010054:0.006305:0.010024:0.008920:0.010054:0.006305:0.004823:0.004248:0.010024:0.008920:0.005564:0.002721:0.009525:0.008920:0.004823:0.003886:0.006305:0.010024:0.008920:0.010054:0.006305:0.010054:0.009525:0.009480:0.004248:0.009525:0.010024:0.005564:0.009827:0.004188
with  time  or  if  preceded  by  a  short  period  of  topical :@0.519050:0.145255:0.927960:0.145255:0.927960:0.129472:0.519050:0.129472:0.012262:0.002721:0.004823:0.008920:0.004188:0.003886:0.004823:0.002721:0.013879:0.009525:0.004188:0.003886:0.009601:0.004248:0.004188:0.003886:0.002721:0.004445:0.004188:0.003886:0.010009:0.004248:0.009525:0.009480:0.009525:0.010054:0.009525:0.010054:0.004188:0.003886:0.010009:0.007801:0.004188:0.003886:0.010024:0.004188:0.003886:0.005564:0.008920:0.009601:0.004248:0.004823:0.004188:0.003886:0.010009:0.009525:0.004248:0.002721:0.009601:0.010054:0.004188:0.003886:0.009601:0.004445:0.004188:0.003886:0.004823:0.009601:0.010009:0.002721:0.009480:0.010024:0.003024:0.004188
corticosteroid use. High-dose systemic topical calcineurin :@0.519050:0.159456:0.928035:0.159456:0.928035:0.143673:0.519050:0.143673:0.009480:0.009601:0.004248:0.004823:0.002721:0.009480:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.002721:0.010054:0.004551:0.008890:0.005564:0.009525:0.003886:0.004551:0.010024:0.002721:0.009873:0.008920:0.004717:0.010054:0.009601:0.005564:0.009525:0.004551:0.005564:0.007801:0.005564:0.004823:0.009525:0.013879:0.002721:0.009480:0.004551:0.004823:0.009601:0.010009:0.002721:0.009480:0.010024:0.002721:0.004551:0.009480:0.010024:0.002721:0.009480:0.002721:0.008920:0.009525:0.008890:0.004248:0.002721:0.009223:0.004188
inhibitors have been associated with lymphoma. Howev-:@0.519050:0.173657:0.923817:0.173657:0.923817:0.157874:0.519050:0.157874:0.002721:0.008920:0.008920:0.002721:0.010009:0.002721:0.004823:0.009601:0.004248:0.005564:0.004778:0.008920:0.010024:0.008074:0.009525:0.004778:0.010009:0.009525:0.009525:0.008920:0.004778:0.010024:0.005564:0.005564:0.009601:0.009480:0.002721:0.010024:0.004823:0.009525:0.010054:0.004778:0.012262:0.002721:0.004823:0.008920:0.004778:0.002721:0.007801:0.013879:0.010009:0.008920:0.009601:0.013879:0.010024:0.003886:0.004778:0.010024:0.009601:0.012262:0.009525:0.008074:0.005020
er, a systematic review of current data identified no cases :@0.519050:0.187858:0.928035:0.187858:0.928035:0.172075:0.519050:0.172075:0.009525:0.004248:0.003886:0.003674:0.010024:0.003674:0.005564:0.007801:0.005564:0.004823:0.009525:0.013879:0.010024:0.004823:0.002721:0.009480:0.003674:0.004248:0.009525:0.008074:0.002721:0.009525:0.012262:0.003674:0.009601:0.004445:0.003674:0.009480:0.008890:0.004248:0.004248:0.009525:0.008920:0.004823:0.003674:0.010054:0.010024:0.004823:0.010024:0.003674:0.002721:0.010054:0.009525:0.008920:0.004823:0.002721:0.003530:0.003530:0.009525:0.010054:0.003674:0.008920:0.009601:0.003674:0.009480:0.010024:0.005564:0.009525:0.005866:0.004188
of lymphoma associated with topical calcineurin inhibitor :@0.519050:0.202058:0.928005:0.202058:0.928005:0.186276:0.519050:0.186276:0.009601:0.004445:0.004294:0.002721:0.007801:0.013879:0.010009:0.008920:0.009601:0.013879:0.010024:0.004294:0.010024:0.005564:0.005564:0.009601:0.009480:0.002721:0.010024:0.004823:0.009525:0.010054:0.004294:0.012262:0.002721:0.004823:0.008920:0.004294:0.004823:0.009601:0.010009:0.002721:0.009480:0.010024:0.002721:0.004294:0.009480:0.010024:0.002721:0.009480:0.002721:0.008920:0.009525:0.008890:0.004248:0.002721:0.008920:0.004294:0.002721:0.008920:0.008920:0.002721:0.010009:0.002721:0.004823:0.009601:0.004551:0.004188
use.:@0.519050:0.216259:0.547217:0.216259:0.547217:0.200477:0.519050:0.200477:0.008890:0.005564:0.009525:0.004188
8:@0.546909:0.210933:0.551767:0.210933:0.551767:0.201779:0.546909:0.201779:0.004858
Crisaborole:@0.519047:0.245951:0.603412:0.245951:0.603412:0.229452:0.519047:0.229452:0.011793:0.004838:0.003629:0.006652:0.009979:0.009979:0.009676:0.004838:0.009676:0.003629:0.009676
Crisaborole  ointment  2%  is  a  novel  anti-inflammatory :@0.519047:0.262715:0.927987:0.262715:0.927987:0.246932:0.519047:0.246932:0.012292:0.004551:0.003024:0.005866:0.010326:0.010311:0.009903:0.004551:0.009903:0.003024:0.009827:0.004188:0.003629:0.009903:0.003024:0.009223:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003613:0.008376:0.011717:0.004188:0.003629:0.003024:0.005866:0.004188:0.003629:0.010326:0.004188:0.003629:0.009223:0.009903:0.008376:0.009827:0.003024:0.004188:0.003629:0.010326:0.009223:0.005125:0.003024:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.004188
phosphodiesterase inhibitor 4 (pDE4), not yet available :@0.519047:0.276916:0.927987:0.276916:0.927987:0.261133:0.519047:0.261133:0.010311:0.009223:0.009903:0.005866:0.010311:0.009223:0.009903:0.010357:0.003024:0.009827:0.005866:0.005125:0.009827:0.004551:0.010326:0.005866:0.009827:0.005292:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.009903:0.004551:0.005292:0.008376:0.005292:0.005579:0.008950:0.011249:0.008104:0.008376:0.005579:0.004188:0.005292:0.009223:0.009903:0.005125:0.005277:0.008104:0.009827:0.005125:0.005292:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.009827:0.004188
in south Africa. It is an effective and well-tolerated new :@0.519047:0.291117:0.928002:0.291117:0.928002:0.275334:0.519047:0.275334:0.003024:0.009223:0.004279:0.007529:0.009903:0.009192:0.005125:0.009223:0.004279:0.011188:0.004747:0.004551:0.003024:0.009782:0.010326:0.004188:0.004264:0.003417:0.005125:0.004264:0.003024:0.005866:0.004279:0.010326:0.009223:0.004264:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.004264:0.010326:0.009223:0.010357:0.004279:0.012564:0.009827:0.003024:0.003024:0.005020:0.005125:0.009903:0.003024:0.009827:0.004551:0.010326:0.005125:0.009827:0.010357:0.004264:0.009223:0.009827:0.012564:0.004188
topical option for the management of mild- to mode-:@0.519047:0.305317:0.923784:0.305317:0.923784:0.289535:0.519047:0.289535:0.005125:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.005685:0.009903:0.010311:0.005125:0.003024:0.009903:0.009223:0.005670:0.004747:0.009903:0.004551:0.005670:0.005125:0.009223:0.009827:0.005670:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.014182:0.009827:0.009223:0.005125:0.005670:0.009903:0.004747:0.005670:0.014182:0.003024:0.003024:0.010357:0.005020:0.005685:0.005125:0.009903:0.005670:0.014182:0.009903:0.010357:0.009827:0.005020
rate atopic dermatitis in patients older than two years. :@0.519047:0.319518:0.928002:0.319518:0.928002:0.303736:0.519047:0.303736:0.004551:0.010326:0.005125:0.009827:0.005246:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.005246:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.005246:0.003024:0.009223:0.005246:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.005246:0.009903:0.003024:0.010357:0.009827:0.004551:0.005246:0.005125:0.009223:0.010326:0.009223:0.005246:0.005125:0.012564:0.009903:0.005246:0.008104:0.009827:0.010326:0.004551:0.005866:0.004188:0.004188
It has the potential to be used for chronic treatment of :@0.519047:0.333719:0.928017:0.333719:0.928017:0.317937:0.519047:0.317937:0.003417:0.005125:0.004778:0.009223:0.010326:0.005866:0.004778:0.005125:0.009223:0.009827:0.004778:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.004762:0.005125:0.009903:0.004762:0.010311:0.009827:0.004778:0.009192:0.005866:0.009827:0.010357:0.004778:0.004747:0.009903:0.004551:0.004762:0.009782:0.009223:0.004551:0.009903:0.009223:0.003024:0.009782:0.004762:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004762:0.009903:0.004747:0.004188
atopic dermatitis without the adverse effects of topical :@0.519047:0.347920:0.927972:0.347920:0.927972:0.332138:0.519047:0.332138:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.004475:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004475:0.012564:0.003024:0.005125:0.009223:0.009903:0.009192:0.005125:0.004475:0.005125:0.009223:0.009827:0.004475:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.004475:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.005866:0.004475:0.009903:0.004747:0.004475:0.005125:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.004188
corticosteroids.:@0.519047:0.362121:0.629824:0.362121:0.629824:0.346338:0.519047:0.346338:0.009782:0.009903:0.004551:0.005125:0.003024:0.009782:0.009903:0.005866:0.005125:0.009827:0.004551:0.009903:0.003024:0.010357:0.005866:0.004188
10:@0.629812:0.356793:0.639528:0.356793:0.639528:0.347639:0.629812:0.347639:0.004858:0.004858
Phototherapy:@0.519047:0.393488:0.628240:0.393488:0.628240:0.375156:0.519047:0.375156:0.009407:0.010079:0.010751:0.005040:0.010751:0.005040:0.010079:0.010751:0.005376:0.011087:0.011087:0.009743
phototherapy  is an  effective treatment  option  to  im-:@0.519047:0.409857:0.923799:0.409857:0.923799:0.394074:0.519047:0.394074:0.008950:0.009223:0.009903:0.005125:0.009903:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.003281:0.003024:0.005866:0.007499:0.010326:0.009223:0.004188:0.003296:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.007499:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003296:0.009903:0.010311:0.005125:0.003024:0.009903:0.009223:0.004188:0.003296:0.005125:0.009903:0.004188:0.003296:0.003024:0.014182:0.005020
prove skin lesions and reduce itch with remission of at-:@0.519047:0.424058:0.923799:0.424058:0.923799:0.408275:0.519047:0.408275:0.010311:0.004551:0.009903:0.008376:0.009827:0.005352:0.005866:0.007590:0.003024:0.009223:0.005352:0.003024:0.009827:0.005866:0.003024:0.009903:0.009223:0.005866:0.005367:0.010326:0.009223:0.010357:0.005367:0.004551:0.009827:0.010357:0.009192:0.009782:0.009812:0.005367:0.003024:0.005125:0.009782:0.009223:0.005352:0.012564:0.003024:0.005125:0.009223:0.005367:0.004551:0.009827:0.014182:0.003024:0.005866:0.005866:0.003024:0.009903:0.009223:0.005367:0.009903:0.004747:0.005352:0.010326:0.005125:0.005020
opic dermatitis of up to six months. It acts by suppressing :@0.519047:0.438258:0.928002:0.438258:0.928002:0.422476:0.519047:0.422476:0.009903:0.010311:0.003024:0.009782:0.003508:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.003508:0.009903:0.004747:0.003492:0.009192:0.010311:0.003508:0.005125:0.009903:0.003492:0.005866:0.003024:0.007257:0.003508:0.014182:0.009903:0.009223:0.005125:0.009223:0.005866:0.004188:0.003492:0.003417:0.005125:0.003508:0.010326:0.009782:0.005125:0.005866:0.003508:0.010311:0.008104:0.003508:0.005866:0.009192:0.010311:0.010311:0.004551:0.009827:0.005866:0.005866:0.003024:0.009223:0.010175:0.004188
the antigen-presenting  function  of Langerhans’  cells, :@0.519047:0.452459:0.927987:0.452459:0.927987:0.436677:0.519047:0.436677:0.005125:0.009223:0.009827:0.007983:0.010326:0.009223:0.005125:0.003024:0.010175:0.009827:0.009223:0.005020:0.010311:0.004551:0.009827:0.005866:0.009827:0.009223:0.005125:0.003024:0.009223:0.010175:0.004188:0.003780:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.003780:0.009903:0.004747:0.007983:0.006985:0.010326:0.009223:0.010175:0.009827:0.004551:0.009223:0.010326:0.009223:0.005866:0.005307:0.004188:0.003780:0.009782:0.009827:0.003024:0.003024:0.005866:0.004188:0.004188
and induces apoptosis of T-cells and antimicrobial pep-:@0.519047:0.466660:0.923814:0.466660:0.923814:0.450878:0.519047:0.450878:0.010326:0.009223:0.010357:0.004007:0.003024:0.009223:0.010357:0.009192:0.009782:0.009827:0.005866:0.004022:0.010326:0.010311:0.009903:0.010311:0.005125:0.009903:0.005866:0.003024:0.005866:0.004022:0.009903:0.004747:0.004007:0.006441:0.005020:0.009782:0.009827:0.003024:0.003024:0.005866:0.004022:0.010326:0.009223:0.010357:0.004022:0.010326:0.009223:0.005125:0.003024:0.014182:0.003024:0.009782:0.004551:0.009903:0.010311:0.003024:0.010326:0.003024:0.004022:0.010311:0.009827:0.010311:0.005020
tides. It is indicated as second-line treatment after fail-:@0.519047:0.480861:0.923784:0.480861:0.923784:0.465078:0.519047:0.465078:0.005125:0.003024:0.010357:0.009827:0.005866:0.004188:0.005322:0.003417:0.005125:0.005322:0.003024:0.005866:0.005337:0.003024:0.009223:0.010357:0.003024:0.009782:0.010326:0.005125:0.009827:0.010357:0.005322:0.010326:0.005866:0.005322:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.005020:0.003024:0.003024:0.009223:0.009827:0.005322:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005307:0.010326:0.004747:0.005125:0.009827:0.004551:0.005322:0.004747:0.010326:0.003024:0.003024:0.005020
ure of basic measures and topical anti-inflammatories.:@0.519047:0.495062:0.914093:0.495062:0.914093:0.479279:0.519047:0.479279:0.009192:0.004551:0.009827:0.003780:0.009903:0.004747:0.003780:0.010311:0.010326:0.005866:0.003024:0.009782:0.003780:0.014182:0.009827:0.010326:0.005866:0.009192:0.004551:0.009827:0.005866:0.003780:0.010326:0.009223:0.010357:0.003780:0.005125:0.009903:0.010311:0.003024:0.009782:0.010326:0.003024:0.003780:0.010326:0.009223:0.005125:0.003024:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.003024:0.009827:0.005866:0.004188
11:@0.914089:0.489740:0.923805:0.489740:0.923805:0.480586:0.914089:0.480586:0.004858:0.004858
 :@0.923809:0.495038:0.927997:0.495038:0.927997:0.479256:0.923809:0.479256:0.004188
The mode of light therapy depends on age, skin type, :@0.519042:0.509239:0.928012:0.509239:0.928012:0.493457:0.519042:0.493457:0.006441:0.009223:0.009827:0.005518:0.014182:0.009903:0.010357:0.009827:0.005518:0.009903:0.004747:0.005518:0.003024:0.003024:0.010175:0.009223:0.005125:0.005518:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.005518:0.010357:0.009827:0.010311:0.009827:0.009223:0.010357:0.005866:0.005518:0.009903:0.009223:0.005518:0.010326:0.010175:0.009827:0.004188:0.005518:0.005866:0.007590:0.003024:0.009223:0.005518:0.005125:0.008104:0.010311:0.009827:0.004188:0.004188
availability and skin-cancer history. Narrowband UV-B is :@0.519042:0.523440:0.927982:0.523440:0.927982:0.507657:0.519042:0.507657:0.010326:0.008376:0.010326:0.003024:0.003024:0.010326:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004400:0.010326:0.009223:0.010357:0.004369:0.005866:0.007590:0.003024:0.009223:0.005020:0.009782:0.010326:0.009223:0.009782:0.009827:0.004551:0.004369:0.009223:0.003024:0.005866:0.005125:0.009903:0.004551:0.008104:0.004188:0.004369:0.011188:0.010326:0.004551:0.004551:0.009903:0.012564:0.010311:0.010326:0.009223:0.010357:0.004354:0.009903:0.010614:0.005020:0.008678:0.004369:0.003024:0.005866:0.004188
the most commonly recommended, considering its low :@0.519042:0.537641:0.927982:0.537641:0.927982:0.521858:0.519042:0.521858:0.005125:0.009223:0.009827:0.004415:0.014182:0.009903:0.005866:0.005125:0.004430:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.003024:0.008104:0.004430:0.004551:0.009827:0.009782:0.009903:0.014182:0.014182:0.009827:0.009223:0.010357:0.009827:0.010357:0.004188:0.004415:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.003024:0.009223:0.010175:0.004415:0.003024:0.005125:0.005866:0.004430:0.003024:0.009903:0.012564:0.004188
risk and efficacy. According to a recent systematic re:@0.519042:0.551842:0.918789:0.551842:0.918789:0.536059:0.519042:0.536059:0.004551:0.003024:0.005866:0.007590:0.005186:0.010326:0.009223:0.010357:0.005171:0.009827:0.004747:0.003681:0.003681:0.009782:0.010326:0.009782:0.008104:0.004188:0.005171:0.011188:0.009782:0.009782:0.009903:0.004551:0.010357:0.003024:0.009223:0.010175:0.005171:0.005125:0.009903:0.005171:0.010326:0.005186:0.004551:0.009827:0.009782:0.009827:0.009223:0.005125:0.005171:0.005866:0.008104:0.005866:0.005125:0.009827:0.014182:0.010326:0.005125:0.003024:0.009782:0.005186:0.004551:0.009827
-:@0.918789:0.551842:0.923809:0.551842:0.923809:0.536059:0.918789:0.536059:0.005020
view, evidence exists for the use of narrow-band UV-B :@0.519042:0.566043:0.927982:0.566043:0.927982:0.550260:0.519042:0.550260:0.008376:0.003024:0.009827:0.012564:0.004188:0.005760:0.009827:0.008376:0.003024:0.010357:0.009827:0.009223:0.009782:0.009827:0.005760:0.009827:0.007257:0.003024:0.005866:0.005125:0.005866:0.005760:0.004747:0.009903:0.004551:0.005760:0.005125:0.009223:0.009827:0.005760:0.009192:0.005866:0.009827:0.005760:0.009903:0.004747:0.005760:0.009223:0.010326:0.004551:0.004551:0.009903:0.012564:0.005020:0.010311:0.010326:0.009223:0.010357:0.005760:0.009903:0.010614:0.005020:0.008678:0.004188
and UV-A1 in moderate to severe atopic dermatitis, but :@0.519042:0.580244:0.927982:0.580244:0.927982:0.564461:0.519042:0.564461:0.010326:0.009223:0.010357:0.003931:0.009903:0.010614:0.005020:0.011188:0.008376:0.003931:0.003024:0.009223:0.003931:0.014182:0.009903:0.010357:0.009827:0.004551:0.010326:0.005125:0.009827:0.003916:0.005125:0.009903:0.003916:0.005866:0.009827:0.008376:0.009827:0.004551:0.009827:0.003916:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.003931:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004188:0.003931:0.010311:0.009192:0.005125:0.004188
it is rarely used for pUVA.:@0.519042:0.594445:0.696691:0.594445:0.696691:0.578662:0.519042:0.578662:0.003024:0.005125:0.004188:0.003024:0.005866:0.004188:0.004551:0.010326:0.004551:0.009827:0.003024:0.008104:0.004188:0.009192:0.005866:0.009827:0.010357:0.004188:0.004747:0.009903:0.004551:0.004188:0.008950:0.009903:0.010614:0.011188:0.004188
12:@0.696674:0.589118:0.706390:0.589118:0.706390:0.579964:0.696674:0.579964:0.004858:0.004858
systemic therapy:@0.519047:0.625813:0.659150:0.625813:0.659150:0.607481:0.519047:0.607481:0.008735:0.009743:0.007392:0.005040:0.010751:0.015791:0.004032:0.010751:0.004704:0.005040:0.010079:0.010751:0.005376:0.011087:0.011087:0.009743
systemic therapy is indicated for a small subset of patients :@0.519047:0.642181:0.927972:0.642181:0.927972:0.626399:0.519047:0.626399:0.007227:0.007801:0.005564:0.004823:0.009525:0.013879:0.002721:0.009480:0.003719:0.004823:0.008920:0.009525:0.004248:0.010024:0.010009:0.007801:0.003704:0.002721:0.005564:0.003704:0.002721:0.008920:0.010054:0.002721:0.009480:0.010024:0.004823:0.009525:0.010054:0.003719:0.004445:0.009601:0.004248:0.003704:0.010024:0.003719:0.005564:0.013879:0.010024:0.002721:0.002721:0.003719:0.005564:0.008890:0.010009:0.005564:0.009525:0.004823:0.003704:0.009601:0.004445:0.003704:0.010009:0.010024:0.004823:0.002721:0.009525:0.008920:0.004823:0.005866:0.004188
with atopic dermatitis, who are refractory to topical treat-:@0.519047:0.656382:0.923799:0.656382:0.923799:0.640600:0.519047:0.640600:0.012262:0.002721:0.004823:0.008920:0.003976:0.010024:0.004823:0.009601:0.010009:0.002721:0.009480:0.003976:0.010054:0.009525:0.004248:0.013879:0.010024:0.004823:0.002721:0.004823:0.002721:0.005564:0.003886:0.003976:0.012262:0.008920:0.009601:0.003976:0.010024:0.004248:0.009525:0.003976:0.004248:0.009525:0.004445:0.004248:0.010024:0.009480:0.004823:0.009601:0.004248:0.007801:0.003976:0.004823:0.009601:0.003976:0.004823:0.009601:0.010009:0.002721:0.009480:0.010024:0.002721:0.003976:0.004823:0.004248:0.009525:0.010024:0.004823:0.005020
ment and/or phototherapy, or with significantly impaired :@0.519047:0.670583:0.927987:0.670583:0.927987:0.654801:0.519047:0.654801:0.013879:0.009525:0.008920:0.004823:0.004929:0.010024:0.008920:0.010054:0.006305:0.009601:0.004248:0.004929:0.010009:0.008920:0.009601:0.004823:0.009601:0.004823:0.008920:0.009525:0.004248:0.010024:0.010009:0.007801:0.003886:0.004929:0.009601:0.004248:0.004929:0.012262:0.002721:0.004823:0.008920:0.004929:0.005564:0.002721:0.009873:0.008920:0.002721:0.003530:0.003530:0.009480:0.010024:0.008920:0.004823:0.002721:0.007801:0.004929:0.002721:0.013879:0.010009:0.010024:0.002721:0.004248:0.009525:0.010357:0.004188
quality of life.  There are few studies which compare sys-:@0.519047:0.684784:0.923769:0.684772:0.923769:0.668990:0.519047:0.669001:0.010009:0.008890:0.010024:0.002721:0.002721:0.004823:0.007801:0.004717:0.009601:0.004445:0.004717:0.002721:0.002721:0.004445:0.009525:0.004188:0.009087:0.004717:0.006138:0.008920:0.009525:0.004248:0.009525:0.004717:0.010024:0.004248:0.009525:0.004717:0.004445:0.009525:0.012262:0.004717:0.005564:0.004823:0.008890:0.010054:0.002721:0.009525:0.005564:0.004717:0.012262:0.008920:0.002721:0.009480:0.008920:0.004717:0.009480:0.009601:0.013879:0.010009:0.010024:0.004248:0.009525:0.004717:0.005564:0.007801:0.005564:-0.485283
11:@0.612836:0.679474:0.622377:0.679474:0.622377:0.670320:0.612836:0.670320:0.004683:0.004858
temic therapies; hence it is difficult to compare the rela:@0.519047:0.698973:0.919067:0.698973:0.919067:0.683191:0.519047:0.683191:0.004823:0.009525:0.013879:0.002721:0.009480:0.005186:0.004823:0.008920:0.009525:0.004248:0.010024:0.010009:0.002721:0.009525:0.005564:0.003886:0.005186:0.008920:0.009525:0.008920:0.009480:0.009525:0.005186:0.002721:0.004823:0.005186:0.002721:0.005564:0.005186:0.010054:0.002721:0.004445:0.003530:0.003530:0.009480:0.008890:0.002721:0.004823:0.005186:0.004823:0.009601:0.005186:0.009480:0.009601:0.013879:0.010009:0.010024:0.004248:0.009525:0.005186:0.004823:0.008920:0.009525:0.005186:0.004248:0.009525:0.002721:0.010326
-:@0.918764:0.698973:0.923784:0.698973:0.923784:0.683191:0.918764:0.683191:0.005020
tive efficacies of various agents. The most commonly used :@0.519047:0.713174:0.927987:0.713174:0.927987:0.697391:0.519047:0.697391:0.004823:0.002721:0.008074:0.009525:0.003417:0.009525:0.004445:0.003530:0.003530:0.009480:0.010024:0.009480:0.002721:0.009525:0.005564:0.003417:0.009601:0.004445:0.003417:0.008074:0.010024:0.004248:0.002721:0.009601:0.008890:0.005564:0.003417:0.010024:0.009873:0.009525:0.008920:0.004823:0.005564:0.003886:0.003417:0.006138:0.008920:0.009525:0.003417:0.013879:0.009601:0.005564:0.004823:0.003417:0.009480:0.009601:0.013879:0.013879:0.009601:0.008920:0.002721:0.007801:0.003417:0.008890:0.005564:0.009525:0.010357:0.004188
systemic agents are cyclosporine, azathioprine, metho-:@0.519047:0.727375:0.923860:0.727375:0.923860:0.711592:0.519047:0.711592:0.005564:0.007801:0.005564:0.004823:0.009525:0.013879:0.002721:0.009480:0.007212:0.010024:0.009873:0.009525:0.008920:0.004823:0.005564:0.007212:0.010024:0.004248:0.009525:0.007212:0.009480:0.007801:0.009480:0.002721:0.009601:0.005564:0.010009:0.009601:0.004248:0.002721:0.008920:0.009525:0.003886:0.007212:0.010024:0.006123:0.010024:0.004823:0.008920:0.002721:0.009601:0.010009:0.004248:0.002721:0.008920:0.009525:0.003886:0.007212:0.013879:0.009525:0.004823:0.008920:0.009601:0.005020
trexate and mycophenolate mofetil (MMF) and systemic :@0.519047:0.741576:0.927972:0.741576:0.927972:0.725793:0.519047:0.725793:0.004823:0.004248:0.009525:0.006955:0.010024:0.004823:0.009525:0.004974:0.010024:0.008920:0.010054:0.004974:0.013879:0.007801:0.009480:0.009601:0.010009:0.008920:0.009525:0.008920:0.009601:0.002721:0.010024:0.004823:0.009525:0.004974:0.013879:0.009601:0.004445:0.009525:0.004823:0.002721:0.002721:0.004974:0.005277:0.013592:0.013592:0.007030:0.005277:0.004974:0.010024:0.008920:0.010054:0.004974:0.005564:0.007801:0.005564:0.004823:0.009525:0.013879:0.002721:0.009782:0.004188
corticosteroids  (sCs).  Besides  systemic  corticosteroids, :@0.519047:0.755777:0.927972:0.755777:0.927972:0.739994:0.519047:0.739994:0.009480:0.009601:0.004248:0.004823:0.002721:0.009480:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.002721:0.010054:0.005564:0.004188:0.007030:0.005277:0.007227:0.011989:0.007227:0.005277:0.003886:0.004188:0.007030:0.008376:0.009525:0.005564:0.002721:0.010054:0.009525:0.005564:0.004188:0.007030:0.005564:0.007801:0.005564:0.004823:0.009525:0.013879:0.002721:0.009480:0.004188:0.007030:0.009480:0.009601:0.004248:0.004823:0.002721:0.009480:0.009601:0.005564:0.004823:0.009525:0.004248:0.009601:0.002721:0.010054:0.005564:0.004188:0.004188
none of the systemic agents has been approved by the :@0.519047:0.769978:0.928002:0.769978:0.928002:0.754195:0.519047:0.754195:0.008920:0.009601:0.008920:0.009525:0.005216:0.009601:0.004445:0.005216:0.004823:0.008920:0.009525:0.005216:0.005564:0.007801:0.005564:0.004823:0.009525:0.013879:0.002721:0.009480:0.005216:0.010024:0.009873:0.009525:0.008920:0.004823:0.005564:0.005216:0.008920:0.010024:0.005564:0.005216:0.010009:0.009525:0.009525:0.008920:0.005216:0.010024:0.010009:0.010009:0.004248:0.009601:0.008074:0.009525:0.010357:0.004959:0.010009:0.007801:0.005216:0.004823:0.008920:0.009827:0.004188
 :@0.871956:0.769978:0.876189:0.769978:0.876189:0.753479:0.871956:0.753479:0.004233
FDA for the treatment of atopic dermatitis.:@0.519047:0.784179:0.816650:0.784179:0.816650:0.768396:0.519047:0.768396:0.007030:0.010946:0.010886:0.003886:0.004445:0.009601:0.004248:0.003886:0.004823:0.008920:0.009525:0.003886:0.004823:0.004248:0.009525:0.010024:0.004823:0.013879:0.009525:0.008920:0.004823:0.003886:0.009601:0.004445:0.003886:0.010024:0.004823:0.009601:0.010009:0.002721:0.009480:0.003886:0.010054:0.009525:0.004248:0.013879:0.010024:0.004823:0.002721:0.004823:0.002721:0.005564:0.004188
Cyclosporine A:@0.519047:0.813897:0.631533:0.813897:0.631533:0.797398:0.519047:0.797398:0.011793:0.008769:0.009676:0.003629:0.009676:0.006652:0.009979:0.009676:0.004838:0.003629:0.009071:0.009676:0.004233:0.011188
Cyclosporine A (CsA) is an immunomodulator that sup-:@0.519047:0.830788:0.923799:0.830788:0.923799:0.815005:0.519047:0.815005:0.012292:0.008104:0.009782:0.003024:0.009903:0.005866:0.010311:0.009903:0.004551:0.003024:0.009223:0.009827:0.004385:0.011188:0.004385:0.005579:0.012292:0.007529:0.011188:0.005579:0.004385:0.003024:0.005866:0.004400:0.010326:0.009223:0.004385:0.003024:0.014182:0.014182:0.009192:0.009223:0.009903:0.014182:0.009903:0.010357:0.009192:0.003024:0.010326:0.005125:0.009903:0.004551:0.004369:0.005125:0.009223:0.010326:0.005125:0.004385:0.005866:0.009192:0.010311:0.005020
presses T-cells and inhibits  pro-inflammatory cytokines, :@0.519047:0.845116:0.928002:0.845116:0.928002:0.829333:0.519047:0.829333:0.010311:0.004551:0.009827:0.005866:0.005866:0.009827:0.005866:0.006456:0.006441:0.005020:0.009782:0.009827:0.003024:0.003024:0.005866:0.006456:0.010326:0.009223:0.010357:0.006441:0.003024:0.009223:0.009223:0.003024:0.010311:0.003024:0.005125:0.005866:0.004188:0.002268:0.010311:0.004551:0.009903:0.005020:0.003024:0.009223:0.003666:0.003666:0.010326:0.014182:0.014182:0.010326:0.005125:0.009903:0.004551:0.008104:0.006441:0.009782:0.008104:0.005125:0.009903:0.007590:0.003024:0.009223:0.009827:0.005866:0.004188:0.004188
especially IL2. It constitutes effective atopic dermatitis :@0.519047:0.859443:0.928002:0.859443:0.928002:0.843661:0.519047:0.843661:0.009827:0.005866:0.010311:0.009827:0.009782:0.003024:0.010326:0.003024:0.003024:0.008104:0.006169:0.003417:0.006985:0.008376:0.004188:0.006153:0.003417:0.005125:0.006153:0.009782:0.009903:0.009223:0.005866:0.005125:0.003024:0.005125:0.009192:0.005125:0.009827:0.005866:0.006138:0.009827:0.004747:0.004747:0.009827:0.009782:0.005125:0.003024:0.008376:0.009827:0.006153:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.006153:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.004188
treatment for recalcitrant atopic dermatitis in adults and :@0.519047:0.873771:0.928002:0.873771:0.928002:0.857989:0.519047:0.857989:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.003084:0.004747:0.009903:0.004551:0.003084:0.004551:0.009827:0.009782:0.010326:0.003024:0.009782:0.003024:0.005125:0.004551:0.010326:0.009223:0.005125:0.003099:0.010326:0.005125:0.009903:0.010311:0.003024:0.009782:0.003099:0.010357:0.009827:0.004551:0.014182:0.010326:0.005125:0.003024:0.005125:0.003024:0.005866:0.003099:0.003024:0.009223:0.003099:0.010326:0.010357:0.009192:0.003024:0.005125:0.005866:0.003099:0.010326:0.009223:0.010357:0.004188
children, significantly decreasing disease activity within :@0.519047:0.888099:0.927987:0.888099:0.927987:0.872317:0.519047:0.872317:0.009782:0.009223:0.003024:0.003024:0.010357:0.004551:0.009827:0.009223:0.004188:0.004823:0.005866:0.003024:0.010175:0.009223:0.003024:0.003681:0.003681:0.009782:0.010326:0.009223:0.005125:0.003024:0.008104:0.004838:0.010357:0.009827:0.009782:0.004551:0.009827:0.010326:0.005866:0.003024:0.009223:0.010175:0.004838:0.010357:0.003024:0.005866:0.009827:0.010326:0.005866:0.009827:0.004838:0.010326:0.009782:0.005125:0.003024:0.008376:0.003024:0.005125:0.008104:0.004838:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188
two to six weeks of treatment initiation. Induction doses :@0.519047:0.902427:0.928002:0.902427:0.928002:0.886644:0.519047:0.886644:0.005125:0.012564:0.009903:0.004505:0.005125:0.009903:0.004505:0.005866:0.003024:0.007257:0.004521:0.012564:0.009827:0.009827:0.007590:0.005866:0.004521:0.009903:0.004747:0.004505:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004505:0.003024:0.009223:0.003024:0.005125:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004521:0.003417:0.009223:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.004505:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188
are 3-5 mg/kg/day, divided into two daily doses. After :@0.519047:0.916755:0.927987:0.916755:0.927987:0.900972:0.519047:0.900972:0.010326:0.004551:0.009827:0.005428:0.008376:0.005020:0.008376:0.005443:0.014182:0.010175:0.006607:0.007590:0.010175:0.006607:0.010357:0.010326:0.008104:0.004188:0.005443:0.010357:0.003024:0.008376:0.003024:0.010357:0.009827:0.010357:0.005443:0.003024:0.009223:0.005125:0.009903:0.005428:0.005125:0.012564:0.009903:0.005428:0.010357:0.010326:0.003024:0.003024:0.008104:0.005443:0.010357:0.009903:0.005866:0.009827:0.005866:0.004188:0.005443:0.011188:0.004747:0.005125:0.009827:0.004551:0.004188
six weeks, the dose can be tapered down to a main-:@0.519047:0.931083:0.923814:0.931083:0.923814:0.915300:0.519047:0.915300:0.005866:0.003024:0.007257:0.005972:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.005972:0.005125:0.009223:0.009827:0.005957:0.010357:0.009903:0.005866:0.009827:0.005972:0.009782:0.010326:0.009223:0.005972:0.010311:0.009827:0.005972:0.005125:0.010326:0.010311:0.009827:0.004551:0.009827:0.010357:0.005957:0.010357:0.009903:0.012564:0.009223:0.005957:0.005125:0.009903:0.005957:0.010326:0.005972:0.014182:0.010326:0.003024:0.009223:0.005020
tenance dose of 2,5-3 mg/kg/day. Treatment duration :@0.519047:0.945411:0.928002:0.945411:0.928002:0.929628:0.519047:0.929628:0.005125:0.009827:0.009223:0.010326:0.009223:0.009782:0.009827:0.005307:0.010357:0.009903:0.005866:0.009827:0.005307:0.009903:0.004747:0.005307:0.008376:0.004188:0.008376:0.005020:0.008376:0.005322:0.014182:0.010175:0.006607:0.007590:0.010175:0.006607:0.010357:0.010326:0.008104:0.004188:0.005322:0.006441:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.005292:0.010357:0.009192:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188